Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Agarwal Vikas | Chief Accounting Officer | 18 | $0 | $39.3K | 2023-02-22 |
| Diamond Andrew S | Chief Medical Officer | 61 | $0 | $12.60M | 2023-02-22 |
| Thaler Bjorn B | Chief Financial Officer | 53 | $0 | $10.34M | 2023-02-22 |
| Kennedy David P | Director | 60 | $0 | $4.56M | 2023-02-22 |
| Mango Lisa A | General Counsel and Secretary | 157 | $0 | $10.40M | 2023-02-22 |
| Rubin Amir Dan | Chair, CEO and President | 90 | $0 | $211.15M | 2023-02-22 |
| Blumenkranz Mark S. | Director | 9 | $0 | $0 | 2023-02-22 |
| Kalen Holmes | Director | 13 | $0 | $1.29M | 2023-02-22 |
| Lewis-Hall Freda C | Director | 9 | $0 | $0 | 2023-02-22 |
| Auvil Paul R. III | Director | 26 | $0 | $0 | 2023-02-22 |
| TAYLOR SCOTT C | Director | 14 | $0 | $0 | 2023-02-22 |
| TOCIO MARY ANN | Director | 14 | $0 | $0 | 2023-02-22 |
| DUNLEVIE BRUCE | Director, 10% Owner | 38 | $0 | $0 | 2023-02-22 |
| SINGER DAVID B | Director | 6 | $0 | $0 | 2021-07-15 |
| Lockhart Kimber D | Chief Technology Officer | 93 | $0 | $21.20M | 2021-04-21 |
| TC Group Cayman Investment Holdings Sub L.P. | 10% Owner | 1 | $0 | $233.10M | 2020-11-23 |
| Benchmark Founders Fund V-B LP | 10% Owner | 13 | $0 | $0 | 2020-08-24 |
| SPURLOCK STEVEN M | 10% Owner | 7 | $0 | $0 | 2020-08-24 |
| TC Group Cayman Investment Holdings, L.P. | 10% Owner | 1 | $0 | $224.54M | 2020-06-29 |
| TC Group VII, L.L.C. | 10% Owner | 10 | $0 | $0 | 2020-02-04 |
| PEG Digital Growth Fund II L.P. | 10% Owner | 2 | $0 | $0 | 2020-02-04 |
| OAK INVESTMENT PARTNERS XII L P | 10% Owner | 6 | $0 | $0 | 2020-02-04 |
| J.P. Morgan Investment Management Inc. | 10% Owner | 4 | $0 | $0 | 2020-02-04 |
| KAGLE ROBERT | 10% Owner | 12 | $0 | $0 | 2020-02-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 498 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 10,462 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 718 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 725 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 1,014 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 5,294 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 984 | — | $0 | 0 | SEC↗ |
| Blumenkranz Mark S. | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| Blumenkranz Mark S. | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 10,381 | — | $0 | 0 | SEC↗ |
| Blumenkranz Mark S. | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 5,294 | — | $0 | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 5,294 | — | $0 | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 498 | — | $0 | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 725 | — | $0 | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 718 | — | $0 | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 1,014 | — | $0 | 0 | SEC↗ |
| Kalen Holmes | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| Kalen Holmes | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 13,617 | — | $0 | 0 | SEC↗ |
| Kalen Holmes | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 10,462 | — | $0 | 0 | SEC↗ |
| Kalen Holmes | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 5,294 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 498 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 10,462 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 984 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 5,294 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 479 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 483 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 676 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 5,294 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 10,381 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| TAYLOR SCOTT C | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 4,534 | — | $0 | 0 | SEC↗ |
| TAYLOR SCOTT C | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| TOCIO MARY ANN | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 6,602 | — | $0 | 0 | SEC↗ |
| TOCIO MARY ANN | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 20,728 | — | $0 | 0 | SEC↗ |
| TOCIO MARY ANN | Director | D To issuer deriv | 2023-02-22 | 2023-02-24 | 12,214 | — | $0 | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 21,906 | — | $0 | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 16,950 | — | $0 | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 12,907 | — | $0 | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 15,025 | — | $0 | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 1,658 | — | $0 | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 3,116 | — | $0 | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 3,240 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 74,702 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 118,764 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 26,032 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 33,860 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 95,523 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 96,420 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 3,553 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 25,627 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 34,573 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 93,948 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 12,870 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 3,750 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 19,222 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 42,325 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 74,702 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 55,000 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 4,441 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 25,627 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 34,573 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 237,529 | — | $0 | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer deriv | 2023-02-22 | 2023-02-24 | 119,403 | — | $0 | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | D To issuer deriv | 2023-02-22 | 2023-02-24 | 477,612 | — | $0 | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | D To issuer deriv | 2023-02-22 | 2023-02-24 | 2,064,765 | — | $0 | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | D To issuer deriv | 2023-02-22 | 2023-02-24 | 8,645,823 | — | $0 | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | D To issuer deriv | 2023-02-22 | 2023-02-24 | 583,090 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 108,834 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 41,488 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 30,752 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 332,279 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 209,164 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 237,529 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 108,182 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 200,000 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 52,083 | — | $0 | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer deriv | 2023-02-22 | 2023-02-24 | 194,030 | — | $0 | 0 | SEC↗ |
| Auvil Paul R. III | Director | D To issuer | 2023-02-22 | 2023-02-24 | 12,586 | $18.00 | $226.5K | 0 | SEC↗ |
| Blumenkranz Mark S. | Director | D To issuer | 2023-02-22 | 2023-02-24 | 4,534 | $18.00 | $81.6K | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer | 2023-02-22 | 2023-02-24 | 12,586 | $18.00 | $226.5K | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | D To issuer | 2023-02-22 | 2023-02-24 | 665,257 | $18.00 | $11.97M | 0 | SEC↗ |
| Kalen Holmes | Director | D To issuer | 2023-02-22 | 2023-02-24 | 4,534 | $18.00 | $81.6K | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer | 2023-02-22 | 2023-02-24 | 10,285 | $18.00 | $185.1K | 0 | SEC↗ |
| Kennedy David P | Director | D To issuer | 2023-02-22 | 2023-02-24 | 250,779 | $18.00 | $4.51M | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer | 2023-02-22 | 2023-02-24 | 4,534 | $18.00 | $81.6K | 0 | SEC↗ |
| TAYLOR SCOTT C | Director | D To issuer | 2023-02-22 | 2023-02-24 | 7,753 | $18.00 | $139.6K | 0 | SEC↗ |
| TOCIO MARY ANN | Director | D To issuer | 2023-02-22 | 2023-02-24 | 47,298 | $18.00 | $851.4K | 0 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | D To issuer | 2023-02-22 | 2023-02-24 | 8,866 | $18.00 | $159.6K | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | D To issuer | 2023-02-22 | 2023-02-24 | 23,620 | $18.00 | $425.2K | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | D To issuer | 2023-02-22 | 2023-02-24 | 88,385 | $18.00 | $1.59M | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | D To issuer | 2023-02-22 | 2023-02-24 | 99,748 | $18.00 | $1.80M | 0 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | D To issuer | 2023-02-22 | 2023-02-24 | 21,532 | $18.00 | $387.6K | 0 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2023-02-17 | 2023-02-17 | 6,150 | $15.32 | $94.2K | 88,385 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | S Sale | 2023-02-16 | 2023-02-17 | 2,117 | $15.36 | $32.5K | 8,866 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2023-02-16 | 2023-02-17 | 7,596 | $15.36 | $116.7K | 94,535 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | S Sale | 2023-02-16 | 2023-02-17 | 6,015 | $15.36 | $92.4K | 21,532 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 4,303 | — | $0 | 12,907 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 829 | — | $0 | 1,658 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 11,525 | — | $0 | 34,573 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 1,776 | — | $0 | 3,553 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2023-02-15 | 2023-02-17 | 2,221 | — | $0 | 4,441 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2023-02-15 | 2023-02-17 | 11,525 | — | $0 | 34,573 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 13,829 | — | $0 | 41,488 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | M Exercise | 2023-02-15 | 2023-02-17 | 4,303 | — | $0 | 10,154 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | M Exercise | 2023-02-15 | 2023-02-17 | 829 | — | $0 | 10,983 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2023-02-15 | 2023-02-17 | 11,525 | — | $0 | 21,844 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2023-02-15 | 2023-02-17 | 1,776 | — | $0 | 23,620 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2023-02-15 | 2023-02-17 | 2,221 | — | $0 | 102,131 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2023-02-15 | 2023-02-17 | 11,525 | — | $0 | 99,910 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise | 2023-02-15 | 2023-02-17 | 13,829 | — | $0 | 27,547 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | A Award deriv | 2023-01-15 | 2023-01-18 | 15,025 | — | $0 | 15,025 | SEC↗ |
| Auvil Paul R. III | Director | A Award | 2023-01-15 | 2023-01-18 | 1,051 | — | $0 | 12,586 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award | 2023-01-15 | 2023-01-18 | 751 | — | $0 | 7,753 | SEC↗ |
| TOCIO MARY ANN | Director | A Award | 2023-01-15 | 2023-01-18 | 751 | — | $0 | 47,298 | SEC↗ |
| Kennedy David P | Director | A Award | 2023-01-15 | 2023-01-18 | 751 | — | $0 | 10,285 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award | 2023-01-15 | 2023-01-18 | 1,051 | — | $0 | 12,586 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | A Award deriv | 2023-01-03 | 2023-01-05 | 95,523 | — | $0 | 95,523 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | A Award deriv | 2023-01-03 | 2023-01-05 | 119,403 | — | $0 | 119,403 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | A Award deriv | 2023-01-03 | 2023-01-05 | 477,612 | — | $0 | 477,612 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | A Award deriv | 2023-01-03 | 2023-01-05 | 194,030 | — | $0 | 194,030 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | S Sale | 2022-12-20 | 2022-12-21 | 6,116 | $16.72 | $102.3K | 13,718 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | S Sale | 2022-12-01 | 2022-12-05 | 200 | $17.00 | $3.4K | 19,834 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-11-21 | 2022-11-23 | 2,500 | — | $0 | 55,000 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-11-21 | 2022-11-23 | 1,602 | — | $0 | 19,222 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-11-21 | 2022-11-23 | 1,602 | $11.56 | $18.5K | 92,487 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-11-21 | 2022-11-23 | 4,102 | $16.58 | $68.0K | 88,385 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-11-21 | 2022-11-23 | 2,500 | $11.47 | $28.7K | 90,885 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-11-17 | 2022-11-17 | 4,312 | $16.71 | $72.1K | 88,385 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | S Sale | 2022-11-17 | 2022-11-17 | 761 | $16.70 | $12.7K | 20,034 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-11-16 | 2022-11-17 | 4,230 | $16.82 | $71.1K | 92,697 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | S Sale | 2022-11-16 | 2022-11-17 | 3,935 | $16.81 | $66.1K | 20,795 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-11-15 | 2022-11-17 | 2,472 | — | $0 | 93,948 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-11-15 | 2022-11-17 | 8,542 | — | $0 | 25,627 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2022-11-15 | 2022-11-17 | 8,542 | — | $0 | 25,627 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise deriv | 2022-11-15 | 2022-11-17 | 10,251 | — | $0 | 30,752 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-11-15 | 2022-11-17 | 2,472 | $12.16 | $30.1K | 90,857 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-11-15 | 2022-11-17 | 2,472 | $16.84 | $41.6K | 88,385 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-11-15 | 2022-11-17 | 8,542 | — | $0 | 96,927 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2022-11-15 | 2022-11-17 | 8,542 | — | $0 | 10,319 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise | 2022-11-15 | 2022-11-17 | 10,251 | — | $0 | 24,730 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise deriv | 2022-11-01 | 2022-11-03 | 10,417 | — | $0 | 52,083 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise | 2022-11-01 | 2022-11-03 | 10,417 | $7.93 | $82.6K | 24,896 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | S Sale | 2022-11-01 | 2022-11-03 | 10,417 | $17.10 | $178.1K | 14,479 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2022-10-24 | 2022-10-25 | 22,251 | — | $0 | 96,420 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2022-10-24 | 2022-10-25 | 45,000 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2022-10-24 | 2022-10-25 | 46,875 | — | $0 | 0 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2022-10-24 | 2022-10-25 | 70,085 | — | $0 | 26,032 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | S Sale | 2022-10-24 | 2022-10-25 | 293,185 | $17.08 | $5.01M | 1,777 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2022-10-24 | 2022-10-25 | 22,251 | $12.16 | $270.6K | 133,002 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2022-10-24 | 2022-10-25 | 45,000 | $6.54 | $294.3K | 178,002 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2022-10-24 | 2022-10-25 | 46,875 | $4.36 | $204.4K | 224,877 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2022-10-24 | 2022-10-25 | 70,085 | $11.56 | $810.2K | 294,962 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-10-21 | 2022-10-25 | 1,602 | — | $0 | 20,824 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-10-21 | 2022-10-25 | 1,602 | $11.56 | $18.5K | 89,987 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-10-21 | 2022-10-25 | 1,602 | $17.08 | $27.4K | 88,385 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-10-19 | 2022-10-19 | 2,500 | — | $0 | 57,500 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-10-19 | 2022-10-19 | 2,500 | $17.06 | $42.6K | 88,385 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-10-19 | 2022-10-19 | 2,500 | $11.47 | $28.7K | 90,885 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-10-17 | 2022-10-19 | 2,472 | — | $0 | 96,420 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-10-17 | 2022-10-19 | 2,472 | $12.16 | $30.1K | 90,857 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-10-17 | 2022-10-19 | 2,472 | $17.06 | $42.2K | 88,385 | SEC↗ |
| Auvil Paul R. III | Director | A Award | 2022-10-15 | 2022-10-18 | 1,023 | — | $0 | 11,535 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award | 2022-10-15 | 2022-10-18 | 1,023 | — | $0 | 11,535 | SEC↗ |
| Kennedy David P | Director | A Award | 2022-10-15 | 2022-10-18 | 730 | — | $0 | 9,534 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award | 2022-10-15 | 2022-10-18 | 730 | — | $0 | 7,002 | SEC↗ |
| TOCIO MARY ANN | Director | A Award | 2022-10-15 | 2022-10-18 | 730 | — | $0 | 46,547 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise deriv | 2022-10-12 | 2022-10-12 | 12,610 | — | $0 | 62,500 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise | 2022-10-12 | 2022-10-12 | 12,610 | $7.93 | $100.0K | 14,479 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise deriv | 2022-10-07 | 2022-10-12 | 1,128,882 | — | $0 | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise deriv | 2022-10-07 | 2022-10-12 | 242,235 | — | $0 | 2,064,765 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | S Sale | 2022-10-07 | 2022-10-12 | 1,371,117 | $17.03 | $23.35M | 99,748 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise | 2022-10-07 | 2022-10-12 | 242,235 | $11.56 | $2.80M | 1,470,865 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise | 2022-10-07 | 2022-10-12 | 1,128,882 | $4.01 | $4.53M | 1,228,630 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise deriv | 2022-10-06 | 2022-10-06 | 1,825,289 | — | $0 | 1,128,882 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | S Sale | 2022-10-06 | 2022-10-06 | 1,825,289 | $17.08 | $31.18M | 99,748 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise | 2022-10-06 | 2022-10-06 | 1,825,289 | $4.01 | $7.32M | 1,925,037 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise deriv | 2022-10-05 | 2022-10-06 | 2,123,402 | — | $0 | 2,954,171 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise | 2022-10-05 | 2022-10-06 | 2,123,402 | $4.01 | $8.51M | 2,223,150 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | S Sale | 2022-10-05 | 2022-10-06 | 2,123,402 | $17.09 | $36.29M | 99,748 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise deriv | 2022-10-04 | 2022-10-06 | 1,589,798 | — | $0 | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise deriv | 2022-10-04 | 2022-10-06 | 24,139 | — | $0 | 5,077,573 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise deriv | 2022-10-04 | 2022-10-06 | 298,570 | — | $0 | 49,890 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-10-04 | 2022-10-06 | 27,234 | — | $0 | 22,426 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-10-04 | 2022-10-06 | 19,779 | — | $0 | 91,293 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-10-04 | 2022-10-06 | 42,500 | — | $0 | 42,564 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-10-04 | 2022-10-06 | 44,325 | — | $0 | 12,870 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | S Sale | 2022-10-04 | 2022-10-06 | 124,689 | $17.18 | $2.14M | 0 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise | 2022-10-04 | 2022-10-06 | 1,589,798 | $4.01 | $6.38M | 1,689,546 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise | 2022-10-04 | 2022-10-06 | 24,139 | $4.01 | $96.8K | 1,713,685 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | S Sale | 2022-10-04 | 2022-10-06 | 1,613,937 | $17.17 | $27.71M | 99,748 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | S Sale | 2022-10-04 | 2022-10-06 | 124,688 | $17.18 | $2.14M | 124,689 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | M Exercise | 2022-10-04 | 2022-10-06 | 298,570 | $7.93 | $2.37M | 327,444 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | S Sale | 2022-10-04 | 2022-10-06 | 325,575 | $17.18 | $5.59M | 1,869 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-10-04 | 2022-10-06 | 44,325 | $7.77 | $344.4K | 222,223 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-10-04 | 2022-10-06 | 133,838 | $17.18 | $2.30M | 88,385 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-10-04 | 2022-10-06 | 27,234 | $11.56 | $314.8K | 135,398 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-10-04 | 2022-10-06 | 42,500 | $11.47 | $487.5K | 177,898 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-10-04 | 2022-10-06 | 19,779 | $12.16 | $240.5K | 108,164 | SEC↗ |
| TOCIO MARY ANN | Director | M Exercise deriv | 2022-09-01 | 2022-09-06 | 3,301 | — | $0 | 6,602 | SEC↗ |
| TOCIO MARY ANN | Director | M Exercise | 2022-09-01 | 2022-09-06 | 3,301 | — | $0 | 45,817 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | M Exercise deriv | 2022-08-15 | 2022-08-16 | 1,080 | — | $0 | 3,240 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | M Exercise | 2022-08-15 | 2022-08-16 | 1,080 | — | $0 | 6,245 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | S Sale | 2022-08-15 | 2022-08-16 | 394 | $17.14 | $6.8K | 5,851 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | A Award deriv | 2022-08-12 | 2022-08-16 | 583,090 | — | $0 | 583,090 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | A Award deriv | 2022-08-08 | 2022-08-10 | 237,529 | — | $0 | 237,529 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | A Award deriv | 2022-08-08 | 2022-08-10 | 237,529 | — | $0 | 237,529 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | A Award deriv | 2022-08-08 | 2022-08-10 | 118,764 | — | $0 | 118,764 | SEC↗ |
| Agarwal Vikas | Chief Accounting Officer | A Award deriv | 2022-07-15 | 2022-07-19 | 21,906 | — | $0 | 21,906 | SEC↗ |
| Auvil Paul R. III | Director | A Award | 2022-07-15 | 2022-07-19 | 1,916 | — | $0 | 10,512 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award | 2022-07-15 | 2022-07-19 | 1,916 | — | $0 | 10,512 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award | 2022-07-15 | 2022-07-19 | 1,369 | — | $0 | 6,272 | SEC↗ |
| TOCIO MARY ANN | Director | A Award | 2022-07-15 | 2022-07-19 | 1,369 | — | $0 | 42,418 | SEC↗ |
| Kennedy David P | Director | A Award | 2022-07-15 | 2022-07-19 | 1,369 | — | $0 | 8,804 | SEC↗ |
| TAYLOR SCOTT C | Director | M Exercise deriv | 2022-06-03 | 2022-06-06 | 2,267 | — | $0 | 4,534 | SEC↗ |
| Auvil Paul R. III | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| Auvil Paul R. III | Director | M Exercise deriv | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 0 | SEC↗ |
| Blumenkranz Mark S. | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| Blumenkranz Mark S. | Director | M Exercise deriv | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 0 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| DUNLEVIE BRUCE | Director | M Exercise deriv | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 0 | SEC↗ |
| Kalen Holmes | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| Kalen Holmes | Director | M Exercise deriv | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | M Exercise deriv | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 0 | SEC↗ |
| Kennedy David P | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| Lewis-Hall Freda C | Director | M Exercise deriv | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| TOCIO MARY ANN | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 20,728 | — | $0 | 20,728 | SEC↗ |
| Auvil Paul R. III | Director | M Exercise | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 8,596 | SEC↗ |
| Blumenkranz Mark S. | Director | M Exercise | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 4,534 | SEC↗ |
| DUNLEVIE BRUCE | Director | M Exercise | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 8,596 | SEC↗ |
| Kalen Holmes | Director | M Exercise | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 4,534 | SEC↗ |
| Kennedy David P | Director | M Exercise | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 7,435 | SEC↗ |
| Lewis-Hall Freda C | Director | M Exercise | 2022-06-02 | 2022-06-06 | 4,534 | — | $0 | 4,534 | SEC↗ |
| TAYLOR SCOTT C | Director | M Exercise | 2022-06-02 | 2022-06-06 | 2,267 | — | $0 | 4,903 | SEC↗ |
| Auvil Paul R. III | Director | A Award | 2022-04-15 | 2022-04-19 | 1,643 | — | $0 | 4,062 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award | 2022-04-15 | 2022-04-19 | 1,643 | — | $0 | 4,062 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award | 2022-04-15 | 2022-04-19 | 1,173 | — | $0 | 2,636 | SEC↗ |
| Kennedy David P | Director | A Award | 2022-04-15 | 2022-04-19 | 1,173 | — | $0 | 2,901 | SEC↗ |
| TOCIO MARY ANN | Director | A Award | 2022-04-15 | 2022-04-19 | 1,173 | — | $0 | 41,049 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2022-02-15 | 2022-10-06 | 2,221 | — | $0 | 6,662 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise deriv | 2022-02-15 | 2022-10-25 | 1,777 | — | $0 | 5,329 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2022-02-15 | 2022-10-06 | 1,422 | $10.26 | $14.6K | 87,277 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2022-02-15 | 2022-10-06 | 2,221 | — | $0 | 88,699 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | M Exercise | 2022-02-15 | 2022-10-25 | 1,777 | — | $0 | 110,751 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | A Award deriv | 2022-01-15 | 2022-01-19 | 332,279 | — | $0 | 332,279 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | A Award deriv | 2022-01-15 | 2022-01-19 | 55,317 | — | $0 | 55,317 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | A Award deriv | 2022-01-15 | 2022-01-19 | 46,098 | — | $0 | 46,098 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | A Award deriv | 2022-01-15 | 2022-01-19 | 118,671 | — | $0 | 118,671 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | A Award deriv | 2022-01-15 | 2022-01-19 | 46,098 | — | $0 | 46,098 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | A Award deriv | 2022-01-15 | 2022-01-19 | 118,671 | — | $0 | 118,671 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award | 2022-01-15 | 2022-01-19 | 768 | — | $0 | 1,463 | SEC↗ |
| Auvil Paul R. III | Director | A Award | 2022-01-15 | 2022-01-19 | 1,075 | — | $0 | 2,419 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award | 2022-01-15 | 2022-01-19 | 1,075 | — | $0 | 2,419 | SEC↗ |
| Kennedy David P | Director | A Award | 2022-01-15 | 2022-01-19 | 768 | — | $0 | 1,728 | SEC↗ |
| TOCIO MARY ANN | Director | A Award | 2022-01-15 | 2022-01-19 | 768 | — | $0 | 39,876 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise deriv | 2021-12-02 | 2021-12-03 | 99,748 | — | $0 | 5,101,712 | SEC↗ |
| Rubin Amir Dan | Chair, CEO and President | M Exercise | 2021-12-02 | 2021-12-03 | 99,748 | $4.01 | $400.0K | 349,125 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | A Award deriv | 2021-11-19 | 2021-11-23 | 74,702 | — | $0 | 74,702 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | A Award deriv | 2021-11-19 | 2021-11-23 | 34,169 | — | $0 | 34,169 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | A Award deriv | 2021-11-19 | 2021-11-23 | 41,003 | — | $0 | 41,003 | SEC↗ |
| Thaler Bjorn B | Chief Financial Officer | A Award deriv | 2021-11-19 | 2021-11-23 | 209,164 | — | $0 | 209,164 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | A Award deriv | 2021-11-19 | 2021-11-23 | 34,169 | — | $0 | 34,169 | SEC↗ |
| Diamond Andrew S | Chief Medical Officer | A Award deriv | 2021-11-19 | 2021-11-23 | 75 | — | $0 | 75 | SEC↗ |
| Auvil Paul R. III | Director | A Award | 2021-10-15 | 2021-10-19 | 810 | — | $0 | 1,344 | SEC↗ |
| Kennedy David P | Director | A Award | 2021-10-15 | 2021-10-19 | 578 | — | $0 | 960 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award | 2021-10-15 | 2021-10-19 | 578 | — | $0 | 695 | SEC↗ |
| TOCIO MARY ANN | Director | A Award | 2021-10-15 | 2021-10-19 | 188 | — | $0 | 39,108 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award | 2021-10-15 | 2021-10-19 | 810 | — | $0 | 1,344 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-09-20 | 2021-09-22 | 2,778 | $24.72 | $68.7K | 250,779 | SEC↗ |
| TOCIO MARY ANN | Director | A Award deriv | 2021-09-01 | 2021-09-03 | 9,903 | — | $0 | 9,903 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-08-18 | 2021-08-20 | 2,778 | $23.40 | $65.0K | 253,557 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-07-19 | 2021-07-19 | 1,878 | $26.75 | $50.2K | 256,335 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-07-19 | 2021-07-19 | 900 | $25.94 | $23.3K | 258,213 | SEC↗ |
| Auvil Paul R. III | Director | A Award | 2021-07-15 | 2021-07-19 | 534 | — | $0 | 534 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award | 2021-07-15 | 2021-07-19 | 534 | — | $0 | 534 | SEC↗ |
| SINGER DAVID B | Director | A Award | 2021-07-15 | 2021-07-19 | 264 | — | $0 | 264 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award | 2021-07-15 | 2021-07-19 | 117 | — | $0 | 117 | SEC↗ |
| Kennedy David P | Director | A Award | 2021-07-15 | 2021-07-19 | 382 | — | $0 | 382 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2021-06-30 | 2021-07-02 | 5,000 | — | $0 | 3,750 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2021-06-30 | 2021-07-02 | 551 | — | $0 | 57,195 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2021-06-30 | 2021-07-02 | 5,000 | $4.01 | $20.1K | 86,077 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2021-06-30 | 2021-07-02 | 551 | $7.77 | $4.3K | 81,077 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-06-18 | 2021-06-22 | 5,556 | $33.60 | $186.7K | 259,113 | SEC↗ |
| DUNLEVIE BRUCE | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 4,534 | — | $0 | 4,534 | SEC↗ |
| Auvil Paul R. III | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 4,534 | — | $0 | 4,534 | SEC↗ |
| Kennedy David P | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 4,534 | — | $0 | 4,534 | SEC↗ |
| Kalen Holmes | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 4,534 | — | $0 | 4,534 | SEC↗ |
| Blumenkranz Mark S. | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 4,534 | — | $0 | 4,534 | SEC↗ |
| Lewis-Hall Freda C | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 4,534 | — | $0 | 4,534 | SEC↗ |
| TAYLOR SCOTT C | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 6,801 | — | $0 | 6,801 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-06-02 | 2021-06-03 | 2,778 | $38.00 | $105.6K | 264,669 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-05-18 | 2021-05-20 | 3,078 | $33.02 | $101.6K | 269,925 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-05-18 | 2021-05-20 | 1,378 | $34.64 | $47.7K | 268,547 | SEC↗ |
| Kennedy David P | Director | S Sale | 2021-05-18 | 2021-05-20 | 1,100 | $35.69 | $39.3K | 267,447 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise deriv | 2021-04-26 | 2021-04-26 | 1,915 | — | $0 | 102,500 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | M Exercise | 2021-04-26 | 2021-04-26 | 1,915 | $11.47 | $22.0K | 82,082 | SEC↗ |
| Mango Lisa A | General Counsel and Secretar | S Sale | 2021-04-26 | 2021-04-26 | 1,915 | $42.15 | $80.7K | 80,167 | SEC↗ |